Clinical trial
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT00167167 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00167167 |
|---|---|
| Title | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia |
| Official title | Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-derived Lymphocytes |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Leukemia, Myeloid, Chronic, AML, MDS, Lymphocytic, Acute |
| Intervention type | Procedure |
| Interventions | Donor Lymphocyte Infusion |
| Enrollment | 40 |
| Start date | Dec 1, 1995 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Nov 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: